Find your next M&A target
Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.
Search Seller Projects – Asia,
Asia - North Asia & China: Korea
Korea condiment company seeks USD 10 million investment
The Korean condiment company has successfully extracted salt from Salicornia, a halophyte flowering plant containing a large amount of salt, and developed the world's first plant based salt with 100% purity. A natural low-sodium salt, which can reduce sodium intake by 20% and have a significant effect on hypertension. The company also desalinated Salicornia and developed a new food that can effectively reduce body fat. In addition, the company developed healthy functional food materials and tea drinks that can effectively improve memory and cognitive ability by using Salicornia. It has 35 patents for Salicornia-based products. The company's round B equity financing seeks USD 10 million.
Asia: Israel
Israeli medical company seeks investment.
The Israeli medical company has developed a surface cryotherapy equipment and system, which can be inserted into the bladder through a cystoscope (endoscope) to visualize the interior of the bladder. Surface cryotherapy is a potential paradigm shift in the treatment of superficial bladder cancer. The reaction of the tissue to the frozen spray can be seen in real-time so that the therapist can assess the destruction of the tissue in real-time and has excellent visualization in all operative stages. The project adopted a new method for treating superficial bladder cancer. It uses surface cryotherapy, which uses extreme cold to freeze and destroy abnormal tissues. Its minimally invasive solution for non-muscle invasive bladder cancer (NMIBC) provides outpatient treatment options for surgery. The company announced that their cryoablation for bladder cancer has made a successful preclinical trial. The company seeks investment for next coming steps.
Asia: Israel
Israeli geriatric care company seeks investment.
The Israeli geriatric care company is developing products aimed at aging. The product is a patented device for making the pill into a delicious gel, which is a movable container with gel inside. The device requires a small disposable glass in which the pill is crushed, and the patient takes the gel. This process only takes 14 seconds. The device will allow patients, especially those with swallowing problems, to receive the pills in a safe and tasty way. The device will be suitable for medical facilities, as well as private customers who care for the elderly at home. The company plans to use this phase of funding to build prototypes of the device and glass, and then build a working model that could be used to mass-produce drug tests. At the same time, the firm will prove the safety of the gel, pursue the patented development on glass. The project has POCs in gel safety, device patents, business plans, and regulatory strategies. The product is scheduled for launch after FDA approval in 2021.
Asia: Israel
Israeli biomedicine R&D company seeks investment.
The Israeli biomedicine R&D company has a project which has been developed and patented. This project aims to reduce the resistance of tumor to conventional treatment. Several diagnostic tests were used to decipher the specific tumor metabolic addiction profile (STMAP), considering the essential nutrients required for tumor proliferation and growth, and the tumor microenvironment profile (TMEP), the cellular environment in which the tumor exists. In addition, the project uses metabolic biomarkers to understand the molecular and cellular mechanisms driving tumor initiation, maintenance and expansion, combined with predictive (diagnostic) metabolic biomarkers to assist in matching targeted therapies (drugs and natural compounds). The company seeks investment for this project.
Asia: Israel
Israeli medical AI imaging company seeks $1.7 million investment.
The Israeli medical AI imaging company is developing a portable real-time diagnostic system, which can be operated by non-experts at first aid, remote areas, medical centers, military, and hospital beds. Lower prices than advanced imaging systems allow products to be more widely spread. The product is a combination of hardware (RF) products and software (AI), which has been proved to be physically feasible. The company has worked with doctors in several hospitals and passed the review of innovation by the Sheba Medical Center. The technology-based on harmless mobile phone RF radiation and non-imaging artificial intelligence runs on local hardware and can be wirelessly connected to hospital equipment. The company seeks investment for $1.7 million at least, as it is the base required to complete the POC of patient data for clinical trials.
Asia: Israel
Israeli telemedicine community seeks strategic partners and looks for professionals.
The Israeli telemedicine community launched six years ago and is the world’s largest online medical community, covering 850,000 doctors and 100 professionals in more than 120 countries around the world. The project enables doctors from all over the world to talk about real-world medicine, solve patient cases through cooperation project members, will participate in online educational activities, and use point-to-point negotiation to solve clinical difficulties and problems. Patients can get answers from professional and proven doctors from different departments so that the community can shorten diagnosis time and improve medical care. The business module of the project provides a unique digital bridge connecting the life sciences of the company and healthcare partners. It provides the global life science industry with practical solutions based on medical population procurement to meet daily challenges that could not be solved before. The company seeks strategic partners and looks for professionals.
Asia: Israel
Israeli biomedical company has a IVF project and seeks investment.
The Israeli biomedicine company’s project improves the success rate of IVF treatment based on its proprietary technology, which determines the patient's uterine preparation through continuous real-time monitoring in vivo. This personalized medical solution provides direct information about the condition of the endometrium. At present, it has raised 1.5 million US dollars, which is mainly used to continue clinical trials and expand its intellectual property rights and complete prototype design. It is planned to submit documents for registration within one and a half years upon which the business will start.
Asia: Israel
Israeli biotechnology company seeks investment.
The Israeli biotechnology company has allied with multinational cosmetics companies and obtained scientifically proven results. More importantly, the core ingredient are natural and sustainable compounds extracted from avocado. It is now developing and producing a patented product using sustainable bioactive compounds extracted from avocado as personal care products. The product can treat skin diseases such as psoriasis and atopic dermatitis. More than six years of product development and extensive scientific research have demonstrated the ability to repair the damage, such as skin exposure to ultraviolet radiation and skin inflammatory diseases, in preclinical and clinical studies. The company seeks investment.
Asia: Israel
Israeli injectable implants company seeks $3 million investment.
The Israeli company has developed injectable implants, which can automatically complete the facial wrinkle filling injection procedure, significantly reduce the risk of complications related to manual filler injection, and provide a better cosmetic effect. The project's patented injectable implants device provides enhanced comfort and reduces the risk of vascular complications. Its business model is to make profits by selling syringes, special needles, and other consumables only compatible with the company's equipment. The company is currently seeking to raise $3 million to maintain operations for the next 18 months to manufacture equipment, register more patents, obtain FDA, CE approval, pilot with doctors, launch products, and start sales.
Asia: Israel
Israeli 3D printing company seeks investment.
The company is headquartered in Israel and has 60 employees worldwide. It’s a pioneer in high-volume additive manufacturing systems for automotive, construction, advertising, and other industries. Its business model includes recurring revenue from hardware sales and consumables, and it has built a global sales network. The company was founded to overcome three fundamental barriers associated with additive manufacturing technology: printing speed, size, and end-use materials. Two disruptive technologies were developed which are broadly IP protected by 57 active patents: gel dispensing printing (GDP) and dynamic casting. GDP technology was introduced into the market for the fundamental speed of mass additive manufacturing. It allows large prototypes and models to be produced in hours rather than days or weeks. Dynamic casting technology is an advanced derivation of GDP. It allows the mold shell to be produced at unprecedented speed while the material is dynamically cast into the mold shell. It is also scalable to support materials that cannot be 3D-printed with other technologies in the future. The company is finalising its pre-IPO project.
Asia: Japan
Janpanese healthcare center focusing on cancer treatment seeks investment.
The Japanese healthcare center has the world's smallest and latest heavy particle therapy device, adopts high-speed scanning irradiation method with high accuracy, so realizes the most advanced cancer treatment with the world's leading high-end technology. The center adopts a universal design, which can provide a more comfortable cancer treatment experience for patients. Since the device is in operation, the center has provided treatment for more than 500 patients, including prostate cancer patients, head and neck patients, liver cancer patients, lung cancer patients, pancreatic cancer patients, bone cancer patients, and other patients. The healthcare center seeks investment.
Asia: Japan
Japanese hospital seeks investment.
The Japanese hospital was established in 1994 and is located in Hiroshima. It focuses on the treatment of COPD (chronic obstructive pulmonary disease), gastric ulcer, duodenal ulcer, herpes zoster, and other diseases. In addition, it focuses on hypertension, smoking cessation, gout, dyslipidemia, osteoporosis, amnesia/dementia, constipation. Also, provide professional and characteristic treatment services in the pneumococcal vaccine, influenza vaccination, and other aspects. At present, the company seeks investment.
Enquire for more information about our services, and how we can help solve challenges for your organization
Contact UsOur Clients
Discover our esteemed global clients across diverse sectors. We believe in providing our clients with exceptional service and a commitment to being their partner for growth in Asia.
See what our clients say about us
0
1
2
3